Connectome-Based Prediction of Cocaine Abstinence.


Journal

The American journal of psychiatry
ISSN: 1535-7228
Titre abrégé: Am J Psychiatry
Pays: United States
ID NLM: 0370512

Informations de publication

Date de publication:
01 02 2019
Historique:
pubmed: 5 1 2019
medline: 22 11 2019
entrez: 5 1 2019
Statut: ppublish

Résumé

The authors sought to identify a brain-based predictor of cocaine abstinence by using connectome-based predictive modeling (CPM), a recently developed machine learning approach. CPM is a predictive tool and a method of identifying networks that underlie specific behaviors ("neural fingerprints"). Fifty-three individuals participated in neuroimaging protocols at the start of treatment for cocaine use disorder, and again at the end of 12 weeks of treatment. CPM with leave-one-out cross-validation was conducted to identify pretreatment networks that predicted abstinence (percent cocaine-negative urine samples during treatment). Networks were applied to posttreatment functional MRI data to assess changes over time and ability to predict abstinence during follow-up. The predictive ability of identified networks was then tested in a separate, heterogeneous sample of individuals who underwent scanning before treatment for cocaine use disorder (N=45). CPM predicted abstinence during treatment, as indicated by a significant correspondence between predicted and actual abstinence values (r=0.42, df=52). Identified networks included connections within and between canonical networks implicated in cognitive/executive control (frontoparietal, medial frontal) and in reward responsiveness (subcortical, salience, motor/sensory). Connectivity strength did not change with treatment, and strength at posttreatment assessment also significantly predicted abstinence during follow-up (r=0.34, df=39). Network strength in the independent sample predicted treatment response with 64% accuracy by itself and 71% accuracy when combined with baseline cocaine use. These data demonstrate that individual differences in large-scale neural networks contribute to variability in treatment outcomes for cocaine use disorder, and they identify specific abstinence networks that may be targeted in novel interventions.

Identifiants

pubmed: 30606049
doi: 10.1176/appi.ajp.2018.17101147
pmc: PMC6481181
mid: NIHMS1511306
doi:

Substances chimiques

Cholinesterase Inhibitors 0
Galantamine 0D3Q044KCA

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

156-164

Subventions

Organisme : NIDA NIH HHS
ID : K01 DA039299
Pays : United States
Organisme : NIDA NIH HHS
ID : P50 DA009241
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA035058
Pays : United States

Références

Front Psychiatry. 2014 Feb 27;5:16
pubmed: 24578695
PLoS One. 2017 Nov 20;12(11):e0184923
pubmed: 29155843
Biol Psychiatry. 2011 Feb 1;69(3):260-5
pubmed: 20965498
Perspect Psychol Sci. 2017 Nov;12(6):1100-1122
pubmed: 28841086
Prog Brain Res. 2016;224:155-73
pubmed: 26822358
Drug Alcohol Depend. 2016 Sep 01;166:134-42
pubmed: 27430401
Nat Neurosci. 2016 Jan;19(1):165-71
pubmed: 26595653
Neuropsychopharmacology. 2013 May;38(6):1085-93
pubmed: 23303067
Mol Psychiatry. 2016 May;21(5):680-5
pubmed: 26260493
Nat Commun. 2018 Jul 18;9(1):2807
pubmed: 30022026
Addict Biol. 2017 Nov;22(6):1790-1801
pubmed: 27600492
J Neurosci. 2016 Sep 14;36(37):9547-57
pubmed: 27629707
Brain Res. 2015 Dec 2;1628(Pt A):147-56
pubmed: 25721787
Neuroimage. 2013 Nov 15;82:403-15
pubmed: 23747961
Neuroimage. 2017 Oct 15;160:140-151
pubmed: 28373122
Nat Neurosci. 2017 Feb 23;20(3):365-377
pubmed: 28230847
Addict Biol. 2012 Nov;17(6):1013-25
pubmed: 22458423
J Subst Abuse Treat. 2017 Jan;72:80-88
pubmed: 27590364
Neuron. 2015 Jan 7;85(1):11-26
pubmed: 25569345
Neuropharmacology. 2013 Jan;64:452-63
pubmed: 22735770
J Clin Psychiatry. 2018 Jan/Feb;79(1):
pubmed: 29286595
Addiction. 2000 Sep;95(9):1335-49
pubmed: 11048353
Biol Psychiatry. 2011 Apr 1;69(7):675-83
pubmed: 21126735
Addiction. 2017 Apr;112(4):719-726
pubmed: 27917536
Biol Psychiatry. 2014 May 1;75(9):746-8
pubmed: 23778288
Biol Psychiatry. 2015 Mar 1;77(5):434-44
pubmed: 25481621
Curr Opin Neurobiol. 2013 Aug;23(4):668-74
pubmed: 23510740
Brain. 2017 May 1;140(5):1513-1524
pubmed: 28334915
Neuropsychopharmacology. 2016 Jul;41(8):2112-21
pubmed: 26792441
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt B):143-154
pubmed: 28322982
Neuroimage. 2012 Oct 1;62(4):2281-95
pubmed: 22326834
Nat Neurosci. 2015 Nov;18(11):1664-71
pubmed: 26457551
Nat Protoc. 2017 Mar;12(3):506-518
pubmed: 28182017
JAMA Psychiatry. 2013 Jan;70(1):87-97
pubmed: 22945462
JAMA Psychiatry. 2015 Jun;72(6):584-92
pubmed: 25853901
Neuroreport. 2001 Dec 4;12(17):3683-7
pubmed: 11726774
Curr Addict Rep. 2016 Sep;3(3):332-342
pubmed: 27990326
Psychol Addict Behav. 2013 Jun;27(2):477-88
pubmed: 22775772
Perspect Psychol Sci. 2009 May;4(3):274-90
pubmed: 26158964

Auteurs

Sarah W Yip (SW)

The Department of Psychiatry (Yip, Potenza, Carroll), the Child Study Center (Yip, Scheinost, Potenza), the Department of Radiology and Biomedical Imaging (Scheinost), and the Department of Neuroscience (Potenza), Yale School of Medicine, New Haven, Conn.; and the Connecticut Mental Health Center, New Haven, Conn. (Potenza).

Dustin Scheinost (D)

The Department of Psychiatry (Yip, Potenza, Carroll), the Child Study Center (Yip, Scheinost, Potenza), the Department of Radiology and Biomedical Imaging (Scheinost), and the Department of Neuroscience (Potenza), Yale School of Medicine, New Haven, Conn.; and the Connecticut Mental Health Center, New Haven, Conn. (Potenza).

Marc N Potenza (MN)

The Department of Psychiatry (Yip, Potenza, Carroll), the Child Study Center (Yip, Scheinost, Potenza), the Department of Radiology and Biomedical Imaging (Scheinost), and the Department of Neuroscience (Potenza), Yale School of Medicine, New Haven, Conn.; and the Connecticut Mental Health Center, New Haven, Conn. (Potenza).

Kathleen M Carroll (KM)

The Department of Psychiatry (Yip, Potenza, Carroll), the Child Study Center (Yip, Scheinost, Potenza), the Department of Radiology and Biomedical Imaging (Scheinost), and the Department of Neuroscience (Potenza), Yale School of Medicine, New Haven, Conn.; and the Connecticut Mental Health Center, New Haven, Conn. (Potenza).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH